http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2705952-C
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9388cb841605d5dcfeb6bc6d60f4384a |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate | 2008-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e80b0f627e7c047b63a1bc8a2924fe1f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a3452896dacbac72df046ea7e43f818 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5c1b22c76ca2ff69ee98eea9f0ea449 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fd2a4192f7b0ce71c430dc4f17229aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4180099d06698f0b72f87e2ddf139976 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf26304de75d5e92d0a258e6406fa6ef |
publicationDate | 2018-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2705952-C |
titleOfInvention | Methods for detecting lung cancer and monitoring treatment response |
abstract | A method is described for detecting lung cancer comprising detecting an elevated level of a CTAP III-related biomarker in a biological sample from a subject at risk for developing lung cancer. Further, a method is described for predicting risk of developing lung cancer in a subject comprising detecting an elevated level of a CTAP III-related biomarker in a biological sample from a subject. Additionally, a method of monitoring the success of lung cancer treatment with curative intent is described comprising detecting levels of a CTAP III-related biomarker in a biological sample from a subject undergoing treatment for lung cancer for comparison with the a previous level obtained from the subject. Multivariate analysis may be incorporated into these methods, evaluating such clinical, or demographic risk factors as age, sex, smoking history, smoking status, smoking family history, education level, COPD, socio-economic status, body mass index and lung function. Kits for conducting such methods are described. |
priorityDate | 2007-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 200.